Colitis ulcerosa y bronquiectasias: ¿el tratamiento con tofacitinib podría repercutir en los síntomas respiratorios?-Reference-Cited by-同舟云学术

Colitis ulcerosa y bronquiectasias: ¿el tratamiento con tofacitinib podría repercutir en los síntomas respiratorios?

Published:2020-03 Issue:3 Volume:56 Page:176-178
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:es
Short-container-title:Archivos de Bronconeumología

Author:

León-Román Francisco Xavier,Mesonero-Gismero Francisco,Pintado-Cort Beatriz,López-Frías López-Jurado Alfonso,Maiz-Carro Luis,Gorospe-Sarasúa Luis,Mercedes-Noboa Edwin,Asensio-Sánchez Joaquín,López-San Román Antonio,Nieto-Royo Rosa

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Pulmonary manifestations of inflammatory bowel disease;Ji;World J Gastroenterol,2014

2. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease;Navaneethan;Inflammatory Bowel Dis.,2010

3. Chronic cough in a patient with stable ulcerative colitis: A rare but important extraintestinal manifestation of inflammatory bowel disease;Chad;BMJ Case Rep.,2019

4. Radiological patterns of lung involvement in inflammatory bowel disease;Cozzi;Gastroenterol Res Pract.,2018

5. Thoracic manifestations of inflammatory bowel disease;Black;Chest.,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growing Pulmonary Nodule of Unknown Origin in a 61-Year-Old Woman;The American Journal of Medicine;2023-05

2. Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review;International Immunopharmacology;2022-04

3. The Spectrum of Airway Involvement in Inflammatory Bowel Disease;Clinics in Chest Medicine;2022-03